Does exercise increase or decrease pain? Central mechanisms underlying these two phenomena
Lucas V Lima, Thiago S S Abner, Kathleen A Sluka, Lucas V Lima, Thiago S S Abner, Kathleen A Sluka
Abstract
Exercise is an integral part of the rehabilitation of patients suffering a variety of chronic musculoskeletal conditions, such as fibromyalgia, chronic low back pain and myofascial pain. Regular physical activity is recommended for treatment of chronic pain and its effectiveness has been established in clinical trials for people with a variety of pain conditions. However, exercise can also increase pain making participation in rehabilitation challenging for the person with pain. Animal models of exercise-induced pain have been developed and point to central mechanisms underlying this phenomena, such as increased activation of NMDA receptors in pain-modulating areas. Meanwhile, a variety of basic science studies testing different exercise protocols, show exercise-induced analgesia involves activation of central inhibitory pathways. Opioid, serotonin and NMDA mechanisms acting in rostral ventromedial medulla promote analgesia associated with exercise. This review explores and discusses current evidence on central mechanisms underlying exercised-induced pain and analgesia.
Keywords: animal; central nervous system; exercise; glutamate; hyperalgesia; opioid; pain; physical activity; serotonin.
© 2017 The Authors. The Journal of Physiology © 2017 The Physiological Society.
Figures

Source: PubMed
Prochains essais cliniques
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Pas encore de recrutementMotricité | En bonne santé | Fonction exécutive
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCPas encore de recrutementCarcinome épidermoïde anal
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaPas encore de recrutementLa polyarthrite rhumatoïde | Maladie articulaire dégénérative du genouItalie
-
University of Wisconsin, MadisonAlkermes, Inc.Pas encore de recrutement
-
Virginia Commonwealth UniversityPas encore de recrutement
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount...Pas encore de recrutementKétamine | IRMf | Dépression - Trouble dépressif majeur | SMTr | Dépression résistante au traitement (TRD)États-Unis
-
Weill Medical College of Cornell UniversityBD2 LLCPas encore de recrutementIRMf | Trouble bipolaire (TB) | SMTr | Dépression bipolaire 1États-Unis
-
Xentria, Inc.Pas encore de recrutement
-
Yale UniversityNational Institute of Mental Health (NIMH)Pas encore de recrutement
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecrutementPhéochromocytome | Phéochromocytome/Paragangliome | Phéochromocytome métastatique | Phéochromocytome malin | Phéochromocytome et paragangliome (PPGL)Royaume-Uni
-
Carl Zeiss Meditec-Dublin CoCeRecrutementMembrane épirétinienne | Maladie de la rétine | Dégénérescence maculaire liée à l'âge sec | Anomalie vitréorétinienne | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal...États-Unis
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityRecrutementCLDN18.2 Tumeurs solides positivesChine